Skip to content

Released May 9, 2016, after the close

10-Q filed May 9, 2016, 39 days after period end · 0001144204-16-099991

Q1 2016 · 10-Q
Revenue—
Net Income-$7.01MN/M vs Q1 2015N/M vs Q4 2015
EPS Diluted-$0.38N/M vs Q1 2015N/M vs Q4 2015
Operating Income-$7,070,404N/M
Operating Cash Flow-$6,509,120N/M
Free Cash Flowderived-$6,548,322N/M

What the release said

The release

Same quarter

MetricQ1 2016Q1 2015Q1 2014Q1 2013
Net Income-$7.01M-$2.96M-$5.27M-$1.35M
EPS Diluted-$0.38-$0.23-$0.41-$0.30

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR